SCHEMBL459954

SCHEMBL459954

Cc1cccc(C)c1CCl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.43
CYP1A2 P05177 1/20 0.43
ACHE P22303 2/20 0.42
TSHR P16473 1/20 0.42
ALDH1A1 P00352 4/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA7 P43166 2/20 0.41
CA9 Q16790 2/20 0.41
TAAR1 Q96RJ0 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
HTR1D P28221 1/20 0.36
TRPA1 O75762 2/20 0.36
CD44 P16070 1/20 0.36
ATM Q13315 1/20 0.36
HTT P42858 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
MAPT P10636 1/20 0.33
NPC1 O15118 1/20 0.33
JAK2 O60674 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20897139 0.87 CYP2A6 (0.38) CYP2A6CYP1A2ACHETSHRALDH1A1
SCHEMBL9861759 0.85 TAAR1 (0.43) CYP2A6CYP1A2ALDH1A1TAAR1
SCHEMBL5598362 0.85 TAAR1 (0.37) CYP2A6CYP1A2ACHETSHRALDH1A1
SCHEMBL6213929 0.83 ALDH1A1 (0.48) CYP2A6CYP1A2ACHETSHRALDH1A1
SCHEMBL16771298 0.83 TAAR1 (0.36) CYP2A6CYP1A2ACHETSHRALDH1A1
SCHEMBL11308408 0.83 ACHE (0.48) CYP2A6CYP1A2ACHETSHRALDH1A1
SCHEMBL30831857 0.83 TAAR1 (0.36) CYP2A6CYP1A2ACHETSHRALDH1A1
SCHEMBL9164079 0.81 L3MBTL1 (0.35) CYP1A2ACHETSHRL3MBTL1
SCHEMBL31633434 0.81 L3MBTL1 (0.35) CYP1A2ACHETSHRL3MBTL1
SCHEMBL4172412 0.81 GABRA1 (0.43) CYP1A2ALDH1A1TAAR1HTTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 432 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025215593-A1 AN IMPROVED PROCESS FOR PREPARATION OF ZASTAPRAZAN HETERO LABS LIMITED (IN) 2025-10-16 WO claimed
CN-120117960-A Impurity compound and preparation method thereof 天津全和诚科技有限责任公司 2025-06-10 CN claimed
CN-117777411-A Crosslinked methylene aromatic hydrocarbon high polymer and synthesis method thereof 乐山师范学院 2024-03-29 CN claimed
CN-110540526-B Carane acidyl 1,2, 3-triazole compound and preparation method and application thereof 广西大学 2022-08-30 CN claimed
CN-110540526-A Carane acidyl 1,2, 3-triazole compound and preparation method and application thereof UNIV GUANGXI 2019-12-06 CN claimed
US-20060063797-A1 Process for preparing a substituted imidazopyridine compound ELMAN BJORN 2006-03-23 US claimed
EP-1105391-B1 Imidazo[1,2-a]pyridine compounds that inhibit gastric acid secretion, pharmaceutical compositions thereof, and processes for thier preparation ASTRAZENECA AB (SE) 2004-10-27 EP claimed
CN-122059846-A Method for synthesizing benzyl azide by tubular reactor 山东弗鲁微科技有限公司 2026-05-19 CN disclosed
CN-122011039-A Large-steric-hindrance triazole carbene monodentate palladium compound containing surplus N, N chelating ligand, and preparation method and application thereof 江苏科技大学 2026-05-12 CN disclosed
EP-4736881-A2 CONTROLLED-RELEASE CNP AGONISTS WITH INCREASED NEP STABILITY Ascendis Pharma Growth Disorders A/S (DK) 2026-05-06 EP disclosed
EP-4710947-A2 CONTROLLED-RELEASE CNP AGONISTS WITH REDUCED SIDE-EFFECTS Ascendis Pharma Growth Disorders A/S (DK) 2026-03-18 EP disclosed
EP-3400065-B1 CONTROLLED-RELEASE CNP AGONISTS WITH REDUCED SIDE-EFFECTS ASCENDIS PHARMA GROWTH DISORDERS AS (DK) 2025-12-17 EP disclosed
WO-2025215593-A1 AN IMPROVED PROCESS FOR PREPARATION OF ZASTAPRAZAN HETERO LABS LIMITED (IN) 2025-10-16 WO disclosed
US-4501746-A HERBICIDES; PLANT GROWTH REGULATORS ELI LILLY AND COMPANY (US) 1985-02-26 US disclosed
EP-0064820-A1 Substituted imidazole and imidazoline derivatives and their preparation and use Farmos-Yhtyma Oy (FI) 1982-11-17 EP disclosed
EP-0000002-B1 TETRAHYDROFURANE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES BAYER AG (DE) 1981-08-26 EP disclosed
US-4282388-A HERBICIDES BAYER AKTIENGESELLSCHAFT (DE) 1981-08-04 US disclosed
EP-0002214-B1 BENZYL ETHERS OF CYCLIC 1,2-DIOLS, METHODS FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES BAYER AG (DE) 1981-05-13 EP disclosed
EP-0002214-A1 Benzyl ethers of cyclic 1,2-diols, methods for their preparation and their use as herbicides BAYER AG (DE) 1979-06-13 EP disclosed
US-4146384-A Tetrahydrofuran-ether compounds and herbicidal compositions BAYER AKTIENGESELLSCHAFT (DE) 1979-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063797-A1 Process for preparing a substituted imidazopyridine compound NISCH, CYP1B1, CYP1A2 CYP2A6 58/4885CYP1A2 3/4885ACHE 2144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.